GNH USA

USA — NDC

BREZTRI 160 ug/1

BREZTRI 160 ug/1 is a combination inhaler containing budesonide, glycopyrrolate, and formoterol fumarate. It is designed for respiratory conditions, offering a

Budesonide, Glycopyrrolate, and Formoterol Fumarate
BREZTRI
AEROSOL, METERED
160 ug/1

Request sourcing

1
Pack/s

What is Budesonide, Glycopyrrolate, and Formoterol Fumarate?

BREZTRI 160 ug/1 is a combination inhaler containing budesonide, glycopyrrolate, and formoterol fumarate. It is designed for respiratory conditions, offering a convenient treatment option for managing symptoms. This metered aerosol inhaler is manufactured by AstraZeneca Pharmaceuticals LP in the USA.

What is Budesonide, Glycopyrrolate, and Formoterol Fumarate used for?

BREZTRI 160 ug/1 is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). This combination inhaler works by reducing inflammation and relaxing the airways, making it easier to breathe. It is often prescribed for individuals who require a combination of bronchodilators and corticosteroids to manage their symptoms effectively. What is BREZTRI used for? It is typically used to improve lung function and reduce the frequency of exacerbations in COPD patients.

What are the side effects of Budesonide, Glycopyrrolate, and Formoterol Fumarate?

Common effects of BREZTRI 160 ug/1 may include throat irritation, hoarseness, and dry mouth. Some users might experience headaches or tremors. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare provider. The inhaler is designed to deliver medication directly to the lungs, which can help minimize systemic side effects.

What precautions apply to Budesonide, Glycopyrrolate, and Formoterol Fumarate?

BREZTRI 160 ug/1 should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions to ensure effective and safe use. Patients with a history of heart conditions, high blood pressure, or thyroid problems should use this inhaler with caution. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

What does Budesonide, Glycopyrrolate, and Formoterol Fumarate interact with?

BREZTRI 160 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is important to discuss all current medications with a healthcare provider to avoid adverse interactions. Alcohol consumption should be moderated, as it may exacerbate some side effects. Additionally, this inhaler should not be used in conjunction with other long-acting beta-agonists without medical supervision.

Frequently asked questions

What is BREZTRI 160 ug/1 used for?+
BREZTRI 160 ug/1 is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It helps reduce inflammation and relax the airways to improve breathing.
How should BREZTRI 160 ug/1 be administered?+
BREZTRI 160 ug/1 is administered via inhalation. Follow the instructions provided by your healthcare provider or the product label for proper use.
What are the common side effects of BREZTRI 160 ug/1?+
Common side effects may include throat irritation, hoarseness, dry mouth, headaches, and tremors. These effects are usually mild and temporary.
Can BREZTRI 160 ug/1 be used with other medications?+
BREZTRI 160 ug/1 may interact with other medications, so it is important to discuss all current medications with a healthcare provider to avoid adverse interactions.
Is BREZTRI 160 ug/1 safe for long-term use?+
BREZTRI 160 ug/1 is designed for long-term use in the management of COPD. However, regular follow-ups with a healthcare provider are recommended to monitor its effectiveness and safety.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Budesonide, Glycopyrrolate, and Formoterol Fumarate
Brand
BREZTRI
Strength
160 ug/1
Form
AEROSOL, METERED
Route
RESPIRATORY (INHALATION)
Pack size
28 AEROSOL, METERED in 1 INHALER (0310-4616-39)
Manufacturer
AstraZeneca Pharmaceuticals LP
Origin
USA

Related products